Jalal, K.; Carter, R.L.; Barczykowski, A.; Tomatsu, S.; Langan, T.J.
A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease. Int. J. Neonatal Screen. 2022, 8, 61.
https://doi.org/10.3390/ijns8040061
AMA Style
Jalal K, Carter RL, Barczykowski A, Tomatsu S, Langan TJ.
A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease. International Journal of Neonatal Screening. 2022; 8(4):61.
https://doi.org/10.3390/ijns8040061
Chicago/Turabian Style
Jalal, Kabir, Randy L. Carter, Amy Barczykowski, Shunji Tomatsu, and Thomas J. Langan.
2022. "A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease" International Journal of Neonatal Screening 8, no. 4: 61.
https://doi.org/10.3390/ijns8040061
APA Style
Jalal, K., Carter, R. L., Barczykowski, A., Tomatsu, S., & Langan, T. J.
(2022). A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease. International Journal of Neonatal Screening, 8(4), 61.
https://doi.org/10.3390/ijns8040061
